BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 17116440)

  • 1. Antibiotic therapy for Helicobacter pylori.
    Collins J; Ali-Ibrahim A; Smoot DT
    Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Helicobacter pylori.
    Bytzer P; O'Morain C
    Helicobacter; 2005; 10 Suppl 1():40-6. PubMed ID: 16178970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of Helicobacter pylori in the etiology of peptic ulcer and its therapy].
    Köksal H
    Mikrobiyol Bul; 1993 Jul; 27(3):266-70. PubMed ID: 8361417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Kodama M; Fujioka T
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1048-53. PubMed ID: 16724993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection: detection, investigation, and management.
    Czinn SJ
    J Pediatr; 2005 Mar; 146(3 Suppl):S21-6. PubMed ID: 15758899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving therapies for peptic ulcer disease: Helicobacter pylori treatment.
    Cohen JC
    Gastroenterologist; 1995 Dec; 3(4):289-300. PubMed ID: 8775091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and the pathogenesis of gastroduodenal disease: Implications for the management of peptic ulcer disease.
    Rotimt O; Nduduba DA; Otegbeye FM
    Niger Postgrad Med J; 2005 Dec; 12(4):289-98. PubMed ID: 16380742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for therapy against Helicobacter pylori].
    Seensalu R; Glise H; Nyrén O
    Lakartidningen; 1994 May; 91(19):1927-8. PubMed ID: 8189939
    [No Abstract]   [Full Text] [Related]  

  • 12. What is new related to Helicobacter pylori infection in children and teenagers?
    Kato S; Sherman PM
    Arch Pediatr Adolesc Med; 2005 May; 159(5):415-21. PubMed ID: 15867113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection in the Caribbean: update in management.
    Lee MG; Barrow KO; Edwards CN
    West Indian Med J; 2001 Mar; 50(1):8-10. PubMed ID: 11398298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation.
    Andreson H; Sillakivi T; Peetsalu M; Peetsalu A; Mikelsaar M
    Scand J Gastroenterol; 2007 Mar; 42(3):324-9. PubMed ID: 17354111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New S3 guideline of DGVS for eradication of Helicobacter pylori--recommendations for routine general practice. Focus on the stomach bacterium].
    MMW Fortschr Med; 2009 May; 151(22):48-9. PubMed ID: 19526970
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication: are there alternatives to antibiotics?
    Gaby AR
    Altern Med Rev; 2001 Aug; 6(4):355-66. PubMed ID: 11578252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.